New Zealand markets open in 4 hours 59 minutes

Wuhan YZY Biopharma Co., Ltd. (2496.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
7.4500.000 (0.00%)
At close: 02:22PM HKT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
Assets
Current assets
Cash
Cash and cash equivalents
196,684
153,520
83,085
Other short-term investments
-
47,000
19,500
Total cash
196,684
200,520
102,585
Inventory
5,770
10,623
8,914
Total current assets
250,101
238,957
125,638
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
110,953
109,097
108,246
Accumulated depreciation
-60,434
-54,419
-48,132
Net property, plant and equipment
50,519
54,678
60,114
Total non-current assets
51,523
63,885
74,517
Total assets
301,624
302,842
200,155
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
89,500
76,500
28,000
Accounts payable
2,954
3,214
5,380
Other current liabilities
40,843
33,761
-
Total current liabilities
173,820
146,960
56,908
Non-current liabilities
Total non-current liabilities
150
0
83
Total liabilities
173,970
146,960
56,991
Stockholders' equity
Common stock
193,849
182,000
0
Retained earnings
-412,788
-221,086
-572,436
Total stockholders' equity
127,654
155,882
143,164
Total liabilities and stockholders' equity
301,624
302,842
200,155